comprehensive -WSS

comprehensive

author：hotspot 2025-09-04 04:27:18 - browse：76

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： $1 billion proposal to grow Boston, Massachusetts biotech

focus

WSS

PhRMA sues HHS over Medicare drug price negotiation

The public health thinking behind the CDC’s new Covid guidance

RaDonda Vaught case: a double standard for nurses, physicians

Ozempic has benefits for kidney disease as well as diabetes

The untold story of TV’s first prescription drug ad

PhRMA sues HHS over Medicare drug price negotiation

focus

comprehensive

explore

How one medical school became remarkably diverse

Did the public have the right to know Arthur Ashe had AIDS?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

For AI in health care standards, federal regulators join with industry group

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

These geoengineering technologies could help combat the climate crisis, scientists say

Continuity nursing helped my family in our darkest PICU moments

Pregnant women don't need prenatal multivitamins, study concludes

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

knowledge

A new study asks: Are we harming blood donors by taking blood?

New case study details death in closely watched Alzhiemer's trial

Families look for replacement for GSK asthma drug Flovent

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Florida health officials providing scant details on measles cases

Pfizer's Covid pill remains 89% effective in final analysis, company says

Wikipedia

focus

focus

focus